A large retrospective cohort study of 143,517 patients reveals that non-eosinophilic acute exacerbations of COPD carry a significantly higher one-year risk of major adverse cardiovascular events compared with eosinophilic exacerbations, suggesting blood eosinophil count as a potential biomarker for cardiovascular risk stratification in COPD.